These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9470)
21. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice]. Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726 [TBL] [Abstract][Full Text] [Related]
22. Short-term prospective comparison of prepulse inhibition between schizophrenic patients and healthy controls. Preuss UW; Zimmermann J; Watzke S; Langosch J; Siafarikas N; Wong JW; Hamm A; Weike A Pharmacopsychiatry; 2011 May; 44(3):102-8. PubMed ID: 21432751 [TBL] [Abstract][Full Text] [Related]
23. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis]. Potvin S; Stip E; Roy JY Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543 [TBL] [Abstract][Full Text] [Related]
25. [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature]. Woggon B Int Pharmacopsychiatry; 1979; 14(1):34-56. PubMed ID: 39040 [TBL] [Abstract][Full Text] [Related]
26. Management of schizophrenia with substance use disorders. Lybrand J; Caroff S Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886 [TBL] [Abstract][Full Text] [Related]
27. Logical processing, affect, and delusional thought in schizophrenia. Mujica-Parodi LR; Malaspina D; Sackeim HA Harv Rev Psychiatry; 2000; 8(2):73-83. PubMed ID: 10902096 [TBL] [Abstract][Full Text] [Related]
28. [The effect of neuroleptics on the social behavior disorders of schizophrenic patients]. Mahé V Encephale; 2003 Sep; 29(Pt 2):S28-30. PubMed ID: 14710533 [No Abstract] [Full Text] [Related]
29. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success]. Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869 [No Abstract] [Full Text] [Related]
35. Treating schizophrenia - Thinking beyond the choice of antipsychotic. Lugg W Aust N Z J Psychiatry; 2022 Mar; 56(3):214-215. PubMed ID: 34348478 [No Abstract] [Full Text] [Related]
36. A STUDY OF SCHIZOPHRENIC THINKING: ITS EXPRESSION IN TERMS OF SYMBOLIC LOGIC AND ITS REPRESENTATION IN TERMS OF MULTI-DIMENSIONAL SPACE. MATTE-BLANCO I Int J Psychiatry; 1965 Jan; 1():91-6. PubMed ID: 14252259 [No Abstract] [Full Text] [Related]
37. Ordinary logic in unordinary lay theories: a key to understanding proneness to medication nonadherence in schizophrenia. Navon L; Ozer N Arch Psychiatr Nurs; 2003 Jun; 17(3):108-16. PubMed ID: 12840803 [TBL] [Abstract][Full Text] [Related]
38. Loose associations: straight and crooked thinking and the group of schizophrenias. McLeod WR Aust N Z J Psychiatry; 1978 Dec; 12(4):221-31. PubMed ID: 33652 [TBL] [Abstract][Full Text] [Related]
39. A comprehensive view on affect and logic. Some implications for treatment and prevention of schizophrenia. Dauwalder JP Psychopathology; 1988; 21(2-3):95-110. PubMed ID: 3074332 [No Abstract] [Full Text] [Related]
40. Are people with schizophrenia more logical than healthy volunteers? Owen GS; Cutting J; David AS Br J Psychiatry; 2007 Nov; 191():453-4. PubMed ID: 17978328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]